p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens

Authors:	Bottini, A. Dogliotti, L. Bersiga, A. Brizzi, M. P. Berruti, A.

Affiliation:	¹ Breast Unit Azienda Ospedaliera Istituti Ospitalieri, Cremona; ² Oncologia Medica Azienda Ospedaliera San Luigi Orbassano; ³ Anatomia Patologica Azienda Ospedaliera Istituti Ospitaliera, Cremona, Italy

Abstract:	Primary chemotherapy administered to breast cancer patientsis the best model to identify baseline features able to predictwhich patients may be most likely to benefit or not from a cytotoxicregimen. In the March issue of Annals of Oncology two papersevaluated the predictive role of immunohistochemical p53 expressionon

Keywords:
本文献已被 Oxford 等数据库收录！